Fundraising Fox

Ambrosia

Jerusalem, IL · 3 known investors

Find your way into Ambrosia

Ambrosia Bio produces rare sugars such as Allulose as low- to no-calorie replacements for sugar, offering a similar taste, sweetness, and textural profile without artificial aftertaste. Its portfolio is intended for food producers seeking sugar alternatives and is stated to be safe for diabetic use.

BiotechFoodTech

Investors · 3

Animoca BrandsHong Kong · $1.5M – $40Mvia Yat Siu · inferred
BrincHong Kong · $100K – $500K
REDMILEreportedSan Francisco

In the news

Ambrosia Biosciences bags $100m for obesity drugsbioxconomy.com · Apr 2026Ambrosia Raises $100M to Develop Small Molecule GLP-1 Drugs - Boulder Todaynationaltoday.com · Apr 2026Ambrosia Biosciences Announces $100 Million Oversubscribed Series B Financing to Advance Novel Small Molecule Cardiometabolic Pipelineprnewswire.com · Mar 2026Ambrosia Bio raises $100M for oral GLP-1 trial - Boulder Todaynationaltoday.com · Mar 2026Ambrosia Biosciences Raises $100M in Series B Fundingfinsmes.com · Mar 2026Ambrosia Biosciences Raises $25M in Series A Financingfinsmes.com · Dec 2024Ambrosia, the Young Blood Transfusion Startup, Is Quietly Back in Businessonezero.medium.com · Nov 2019

Frequently asked questions

What does Ambrosia do?
Ambrosia Bio produces rare sugars such as Allulose as low- to no-calorie replacements for sugar, offering a similar taste, sweetness, and textural profile without artificial aftertaste. Its portfolio is intended for food producers seeking sugar alternatives and is stated to be safe for diabetic use.
Who are Ambrosia's investors?
Ambrosia's investors include Animoca Brands, Brinc, REDMILE.
Where is Ambrosia headquartered?
Ambrosia is headquartered in Jerusalem, IL.